bleomycin/cyclophosphamide/doxorubicin/prednisone/vincristine protocol

Known as: CA-BOP, CHOP-B, BLEO/CTX/DOX/PRED/VCR 
A chemotherapy combination consisting of bleomycin, cyclophosphamide, doxorubicin, prednisone, and vincristine.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2009
051019762009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
PURPOSE Advanced-stage follicular lymphoma is considered incurable. The pace of improvements in treatment has been slow. This… (More)
Is this relevant?
2003
2003
PURPOSE The array of options for the initial management of follicular small cleaved lymphoma (FSCL) and follicular mixed lymphoma… (More)
Is this relevant?
1994
1994
BACKGROUND Numerous treatment strategies have been tried with the aim of improving results for patients with intermediate-grade… (More)
Is this relevant?
1993
1993
PURPOSE Treatment of lymphomas with combination chemotherapy with or without radiation therapy (XRT) can result in long-term or… (More)
Is this relevant?
1991
1991
We analyzed the records of 96 previously untreated patients with stage IV follicular low-grade lymphoma (FLGL) uniformly treated… (More)
Is this relevant?
1990
1990
Thirty-four patients with stages IE and IIE gastric lymphoma were treated with chemotherapy and radiotherapy combinations without… (More)
Is this relevant?
1990
1990
We report the clinical findings of 21 consecutive patients affected by mediastinal large B-cell lymphoma with sclerosis. This… (More)
Is this relevant?
1989
1989
Two hundred and fifty previously untreated adult patients with diffuse large-cell lymphomas were treated with a chemotherapy… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1986
1986
Previously untreated adult patients who presented with advanced diffuse large-cell lymphoma (DLCL) at diagnosis were studied to… (More)
Is this relevant?
1976
1976
A new combination chemotherapy program for patients with diffuse histiocytic and mixed histiocytic-lymphocytic lymphoma was… (More)
Is this relevant?